Business Wire

Fluence Supporting Premium Dutch Floriculture Brands to Future-Proof and Increase Sustainability


Fluence, a leading global provider of energy-efficient LED lighting solutions for floriculture, medicinal cannabis and food production, is supporting sustainability and operational cost efficiency amid volatile energy market conditions in Europe.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

Orchids under Fluence LED lighting at Bernhard Kwekerijen, a rose, orchid and patio plant nursery. (Photo: Business Wire)

Europe’s soaring energy prices have affected many growers in countries like the Netherlands that primarily produce electricity via the gas-powered cogeneration method. Gas prices have historically balanced between €15 and €20 per megawatt-hour (MWh) but peaked at over €300 per MWh in 2022 because of volatility due to supply, storage and weather conditions. Current energy prices have dropped to €60 per MWh, remaining roughly three times higher than what many growers planned to pay for electricity.

Leading floriculture companies dedicated to delivering high-quality products to customers—including Bernhard Kwekerijen, Moerman Lilium, Deliflor Chrysanten, Beyond Chrysant and Ten Have Plant—have made the switch from high-pressure sodium (HPS) fixtures to Fluence's LED technology, which increase photon output and energy efficiency.

“As they confront the unpredictability of Europe’s energy market, Dutch cultivators are increasingly focused on future-proofing their cultivation strategies by decreasing their dependency on fossil energy and engaging in sustainable practices,” said Gert-Jan Goes, horticulture specialist at Fluence. “Fluence’s RAPTR light fixture and Wireless Flex Dimming control panel help growers maximize their return on investment while increasing control over light intensity while increasing control over light intensity and dimming up and down creates maximum flexibility to profit from highly fluctuating energy markets.”

Moerman Lilium, a lily cultivator, has 13 hectares of crops under full LED lighting and uses Fluence’s RAPTR fixtures regulated via a Wireless Flex Dimming controller. The company—which monitors European energy prices very closely—uses Fluence solutions to react quickly and modify light intensity based on market conditions. Moerman Lilium expects to save at least 45% on electricity costs with the investment in Fluence’s LED lighting solutions.

“LED lighting allows us to be more energy efficient while adjusting our electricity use based on fluctuations in energy prices,” said Jan Moerman, co-owner of Moerman Lilium. “Switching to Fluence LEDs has saved us money and given us more flexibility in a constantly changing energy market.”

Deliflor Chrysanten is the global market leader in breeding and propagating chrysanthemum varieties. The company was in search of a high-efficiency lighting solution featuring additional green light in the spectrum for better visibility and growth. Deliflor Chrysanten opted for Fluence’s RAPTR Broad R8 spectrum in their recently renewed breeding facilities to guarantee the best circumstances for their newest varieties. The first flower trial grown under the Fluence’s fixtures turned out very successful last January. Beyond Chrysant, a leading Dutch chrysanthemum cultivator, also chose Fluence’s RAPTR solution for its customizability and high-visibility spectrum that create increased efficiency in its integrated crop management practices. Installing Fluence’s LED technology has allowed Beyond Chrysant to gain greater control over the oscillating European energy market. The company was recently named a finalist for Stichting Tuinbouw Ondernemersprijs’ “2023 Horticultural Entrepreneur Award.”

Even in hybrid lighting environments, growers are seeing the benefits of using LED technology. Bernhard Kwekerijen—a rose, orchid and patio plant nursery—promotes a carbon-neutral and sustainable operation by using geothermal heat and its own photovoltaic field of solar panels to generate energy. By incorporating Fluence’s RAPTR fixtures alongside legacy HPS solutions and maximizing light control with Wireless Flex Dimming, Bernhard Kwekerijen has elevated CO2-neutral cropping in its Phalaenopsis cultivation.

“Fluence’s technology stands out because it affords the greatest flexibility in modifying energy consumption and light intensity according to energy market price instability,” said Dennis Raadschelders, strategic account manager for commercial agriculture at Fluence. “Our Dutch floriculture growers have harnessed control over operational expenses without sacrificing product quality by emitting more light when energy prices are low, and quickly reducing light when energy prices rise.”

Fluence’s team of horticultural experts work closely alongside partners to design lighting programs based on operations-specific crop and sustainability goals. Ten Have Plant, one of the oldest potted plant nurseries in Westland, selected Fluence as its lighting solutions partner to achieve better crop and root development in addition to reducing costs and increasing energy efficiency. Ten Have Plant worked with Fluence’s horticulture team to design a lighting plan to produce cyclamen for half the year and campanula in the other half, selecting VYPR 3p Broad R6 top lights to gain control over seasonal light conditions and electricity consumption year-round.

“Fluence LED fixtures are widely used by leading cannabis, commercial agriculture and floriculture companies across Europe, demonstrating the flexibility and universal benefit in transitioning to LED technology,” said David Cohen, CEO of Fluence. “We are excited to work with Dutch floriculture growers who have deep roots in the industry and support their management of environmental conditions, sustainable operations and the highest quality crops.”

For more information on Fluence, visit

About Fluence

Fluence Bioengineering, Inc. (Fluence) creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. Fluence operates as a business unit within Signify’s Digital Solutions division. For more information about Fluence, visit

To view this piece of content from, please give your consent at the top of this page.

Contact information

Silvia Nagyova
+49 160 93335045

For North America,
Callie Neatherlin

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001 To San Fu Biotech in Major Asian Countries1.4.2023 19:18:00 EEST | Press release

REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu Chemical Co., Ltd. (4755.TW) have entered a licensing agreement to develop and commercialize RGI-2001 for the prophylaxis of acute Graft-versus-host disease (aGvHD) in major Asian countries. RGI-2001, with the novel mechanism to improve existing treatments, is a potentially first-in-class small molecule drug candidate targeted for preventing aGvHD, a life-threatening complication resulting from allogeneic hematopoietic stem cell transplantation (HSCT). GvHD is a systemic disorder that occurs when the graft's immune cells recognize the host as foreign and attack the recipient’s body cells or organs, and leads to skin rash, liver problems, abdominal pain or cramps, diarrhea, and increased risk for infections. Patients undergoing allogeneic HSCT have a high-risk of developing aGVHD associated with significant morb

AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2023)31.3.2023 19:00:00 EEST | Press release

AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001. AR1001 is a potent PDE5 inhibitor with preliminary efficacy in cognition, and preclinical effects on neuron apoptosis inhibition, promotion of neurogenesis, increase in neuroplasticity, and stimulation of autophagy to remove toxic proteins. The phase 2 study was a double-blind, randomized, placebo-controlled, multi-center trial to evaluate the safety and preliminary efficacy of AR1001 over 26 and 52 weeks of treatment in patients with mild to moderate Alzheimer’s disease. The trial enrolled 210 patients at 21 research centers in the United States. Plasma collected from patients at baseline, week 26 and week 52 was analyzed by Quantarix using the Simoa HD-X analyzer. Meaningful, statistically significant changes were found over 52 weeks of treatm

KANEKA: “Development of Polymer Synthesis Technology by Microorganisms using CO2 as Direct Raw Material” selected as a NEDO Green Innovation Fund Project”31.3.2023 17:09:00 EEST | Press release

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd (Headquarters: Kobe-city, Hyogo; President: Mikio Tanji; hereinafter "Bacchus"), JGC Holdings Corporation (Headquarters: Yokohama-city Kanagawa; Chairman and CEO: Masayuki Sato; hereinafter "JGC HD"), and Shimadzu Corporation (Headquarters: Kyoto-city, Kyoto; President: Yasunori Yamamoto; hereinafter "Shimadzu") have announced that the proposal of a joint project, “Development of Polymer Synthesis Technology by microorganisms using CO2 as direct raw material (hereinafter referred to as ‘the Project’)” had been selected by the "Green Innovation Fund Project*1 / Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw Material” as a planned implementation sponsored by the New Energy and Industrial Technology Development Organization (NEDO). This press release features multimedia. View the full release here: https://www.busine

Allianz Appoints Leadership for Allianz Commercial Key Markets31.3.2023 16:11:00 EEST | Press release

As part of the implementation of its ‘Integrated Commercial’ strategy to better serve the full Commercial segment, Allianz Group today announced the leadership for four of its largest Property and Casualty Commercial insurance markets: Australia, France, Germany and the United Kingdom. In each country, the appointed single Commercial lead will represent the integrated Allianz Commercial business and bring to the market Allianz’s full set of solutions for specialty clients, large corporates, and mid-sized companies, simplifying and enhancing the experience of clients and distribution partners. “The appointment of the regional leaders in our core Allianz Commercial markets is an important, concrete step toward realizing our new integrated model, which brings together our Mid Corporate and Large Corporate insurance business for the benefit of our clients and distribution partners,” said Chris Townsend, Member of the Allianz SE Board of Management. Townsend added, “As one face to the marke

Huawei Releases 2022 Annual Report: Steady Operations, Sustainable Survival and Development31.3.2023 12:59:00 EEST | Press release

Huawei released its 2022 Annual Report today. The company reports steady operations throughout 2022, having generated CNY642.3 billion in revenue and CNY35.6 billion in net profits. Huawei continues to strengthen investment in R&D, with an annual expenditure of CNY161.5 billion in 2022, representing 25.1% of the company's annual revenue and bringing its total R&D expenditure over the past 10 years to more than CNY977.3 billion. This press release features multimedia. View the full release here: (Photo: Huawei) "In 2022, a challenging external environment and non-market factors continued to take a toll on Huawei's operations", said Eric Xu, Huawei's Rotating Chairman, at the company's annual report press conference. "In the midst of this storm, we kept racing ahead, doing everything in our power to maintain business continuity and serve our customers. We also went to great lengths to grow the harvest – generating a steady stream

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom